Pharmacology of Cell and Organ Systems
Investigators in the Molecular Pharmacology program are also examining the mechanisms of autonomic synaptic transmission and the autonomic regulation of the urogenital and renal systems. These studies include: 1) neuroanatomical and neurophysiological research aimed towards the development of agents to modulate neuronal control of the urinary bladder, colon, and sex organs; 2) biochemical/molecular analysis of the role of PP-fold peptides released from autonomic synaptic junctions in the regulation of renovascular tone and arterial blood pressure in genetic hypertension; and 3) the interaction between the sympathetic nervous system and estradiol on renal function.

Faculty

aab20@pitt.edu
412-624-8864
bayihx@upmc.edu
412-692-5164
rjb42@pitt.edu
412-3.83-7722
lbirder@pitt.edu
412-383-7368
alb138@pitt.edu
412-648-7347
wcd2@pitt.edu
412-648-9357
dod1@pitt.edu
412-624-4259
paf10@pitt.edu
412-383-7783
edj@pitt.edu
412-648-1505
ajk5@pitt.edu
412-624-1430
leeav@upmc.edu
412-641-7557
lotzemt@upmc.edu
412-623-5977
can44@pitt.edu
412-641-7725
oesterreichs@upmc.edu
412-641-8555
pagano@pitt.edu
412-383-6505
mjp44@pitt.edu
412-383-5900
ggr@pitt.edu
412-648-9408
fjs2@pitt.edu
412-648-0193
sss43@pitt.edu
412-383-5854
astraub@pitt.edu
412-648-7097
vanhoutenb@upmc.edu
412-623-7762
jpv@pitt.edu
412-648-2055
qjw1@pitt.edu
412-383-7754
wex6@pitt.edu
412-648-9941

Student News



Events

Molecular Pharmacology Journal Club
Atinuke Dosunmu-Ogunbi
Thomas E. Starzl Biomedical Science Tower
1395 Conference Room

Recent Publications

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Outcomes: 

Time to dissertation Defense
, last five graduating classes:  4.6 years, Completion Rate: 86.49%

First Author Publications (All students, past 5 year mean):  2.03;   Total Publications: 5.10

F-series Grants (F30/F31) (All Students, past 5 year mean):  12/34 (35%) 


Ranked #9 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty-four consecutive years